STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1575 by analyst upside · 2026-08-12
ESTA
Establishment Labs Holdings Inc.
Healthcare · Market Cap $2B · P/E 0x
ANALYST PRICE TARGET
+37.9%
implied upside to consensus target
Current Price $74.28
Consensus Target $102.44
Bull Target $117.0
Bear Target $92.0
Analysts Covering 9
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
6
Hold
1
Sell
0
52-Week Low $33.35
52-Week High $97.59
YTD Return +7.9%
FUNDAMENTALS
Market Cap $2B
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-1.27
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $246M
Profit Margin -15.8%
52-WEEK RANGE
52-Week Low $33.35
52-Week High $97.59
Current Price $74.28
Bear Target $92.0
Bull Target $117.0
● Now $74.28 ● Target $102.44
TRADING DATA
Avg Volume 613K
YTD Return +7.9%
Analyst Count 9
Consensus Buy
Upside to Target +37.9%
Last Updated 2026-08-12

ANALYST SUMMARY

Establishment Labs Holdings Inc. (ESTA) is currently trading at $74.28 with a Wall Street consensus price target of $102.44, implying potential upside of 37.9% over the next 12 months. 9 analysts currently cover ESTA, with a consensus rating of Buy - 89% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $117.0, while the most cautious has a target of $92.0.

ESTA operates in the Healthcare sector with a market capitalisation of $2B. The stock is up 7.9% year-to-date and is currently trading near the upper end of its 52-week range of $33.35 – $97.59.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for ESTA, with each firm's 90-day track record across all stocks we track. See full firm rankings →

BTIG - Reiterated
Buy → Buy 2026-05-07 38% win rate (8 calls)
BTIG reit
Buy → Buy 2026-04-29 38% win rate (8 calls)
Citigroup - Reiterated
Neutral → Neutral 2026-03-11 Building track record
Canaccord Genuity - Reiterated
Buy → Buy 2026-02-26 Building track record
Stephens & Co. - Reiterated
Overweight → Overweight 2026-02-25 Building track record
Mizuho - Reiterated
Outperform → Outperform 2026-02-25 Building track record
Needham - Reiterated
Buy → Buy 2026-02-24 20% win rate (5 calls)
BTIG - Reiterated
Buy → Buy 2026-02-24 38% win rate (8 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
63
out of 100
Coverage depth
18/30
Consensus clarity
23/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →